The cyclic form of RGD, the iRGD peptide, has increased tumor penetrating abilities compared to RGD due to its ability to efficiently bind the transmembrane glycoprotein neuropilin 1 (NRP-1) in addition to αvβ3 integrins. Here, NRP1 is linked to neoplasm.